View in EDS HTML Full Text PDF Full Text

Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity.

Saved in:
Bibliographic Details
Title: Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity.
Authors: Mougari S; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Favède V; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.; Département du Rhône, Lyon, France., Predella C; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.; Department of Chemistry, Materials and Chemical Engineering 'G. Natta and Department of Electronics, Information and Bioengineering, Politecnico of Milan, Milan, Italy., Reynard O; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Durand S; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Mazelier M; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Pizzioli E; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Decimo D; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Bovier FT; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA., Lapsley LM; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA., Castagna C; Institute of Comparative Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA., Lieberman NAP; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA., Noel G; Institut Claude Bourgelat, VetAgro Sup, Marcy l'Etoile, Lyon, France., Mathieu C; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France., Malissen B; Centre d'Immunophénomique, Aix Marseille Université, Inserm, CNRS, PHENOMIN, Celphedia, Marseille, France., Briese T; Center for Infection and Immunity and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Greninger AL; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA, USA., Alabi CA; Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA., Dorrello NV; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA., Marot S; Sorbonne Université, Virology department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute, INSERM 1136, Paris, France., Marcelin AG; Sorbonne Université, Virology department, Pitié-Salpêtrière hospital, AP-HP, Pierre Louis Epidemiology and Public Health institute, INSERM 1136, Paris, France., Zarubica A; Centre d'Immunophénomique, Aix Marseille Université, Inserm, CNRS, PHENOMIN, Celphedia, Marseille, France., Moscona A; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.; Center for Host-Pathogen Interaction, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.; Department of Microbiology & Immunology and Department of Physiology & Cellular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA., Porotto M; Division of Pediatric Critical Care Medicine and Hospital Medicine, Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. mp3509@cumc.columbia.edu.; Center for Host-Pathogen Interaction, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. mp3509@cumc.columbia.edu.; Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Caserta, Italy. mp3509@cumc.columbia.edu., Horvat B; CIRI, Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France. branka.horvat@inserm.fr.
Source: Communications biology [Commun Biol] 2025 Jan 15; Vol. 8 (1), pp. 57. Date of Electronic Publication: 2025 Jan 15.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2399-3642
DOI:10.1038/s42003-025-07491-4